Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: A novel mechanism of hypoxic pulmonary hypertension

Circulation Research

Volumn 95, Issue 5, 2004, Pages 496-505

  Lin, Mo Jun ^a,c   Leung, George P H ^a   Zhang, Wei Min ^a   Yang, Xiao Ru ^a   Yip, Kay Pong ^b   Tse, Chung Ming ^a   Sham, James S K ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c FUJIAN MEDICAL UNIVERSITY   (China)

^d JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Pulmonary hypertension; Receptor operated Ca2+ channels; Store operated Ca2+ channels; Transient receptor potential channels

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CALCIUM CHANNEL; CALCIUM ION; CATION CHANNEL; GLYCEROL 2 ACETATE 1 OLEATE; LANTHANUM; MANGANESE; SMALL INTERFERING RNA; THAPSIGARGIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; RECEPTOR OPERATED CALCIUM CHANNEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STORE OPERATED CALCIUM CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 2; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; WESTERN BLOTTING;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CATIONS; CELL HYPOXIA; CELLS, CULTURED; DIGLYCERIDES; HYPERTENSION, PULMONARY; ION TRANSPORT; MALE; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RATS; RATS, WISTAR; RNA INTERFERENCE; THAPSIGARGIN; TRPC CATION CHANNELS; UP-REGULATION;

EID: 4444352981     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000138952.16382.ad     Document Type: Article

References (41)

1. Shimoda LA, Sham JSK, Sylvester JT. Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res. 2000;49:549-560.
2. + channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest. 1997;100:2347-2353.
3. v channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol. 2001;280:L801-L812.
4. Reeve HL, Michelakis E, Nelson DP, Weir EK, Archer SL. Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol. 2001;90:2249-2256.
5. i, and ET-1-induced responses in chronically hypoxic pulmonary myocytes. Am J Physiol Lung Cell Mol Physiol. 2000;279:L884-L894.
6. + currents in pulmonary arterial myocytes. Am J Physiol. 1999;277:L431-L439.
7. + current in rat pulmonary artery muscle cells. Am J Physiol. 1994;266:H365-H370.
8. Fike CD, Kaplowitz MR. Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs. Am J Physiol. 1999;277:L449-L456.
9. Kennedy TP, Michael JR, Summer W. Calcium channel blockers in hypoxic pulmonary hypertension. Am J Med. 1985;78:18-26.
10. Davidson A, Bossuyt A, Dab I. Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension. Pediatr Pulmonol. 1989;6:53-59.
11. Agostoni P, Doria E, Galli C, Tamborini G, Guazzi MD. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;139:120-125.
12. Oka M, Morris KG, McMurtry IF. NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension. J Appl Physiol. 1993;75:1075-1080.
13. 2+ channels in native vascular smooth muscle cells. Circ Res. 2001;88:84-87.
14. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2002;283:L144-L155.
15. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature. 1999;397:259-263.
16. 2+-permeable cation channel. Circ Res. 2001;88:325-332.
17. Jung S, Strotmann R, Schultz G, Plant TD. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am J Physiol Cell Physiol. 2002;282:C347-C359.
18. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol. 2001;280:H746-H755.
19. 2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001;280: L870-L880.
20. 2+ influx and contraction in rat pulmonary artery. Circ Res. 2001;89:923-929.
21. Walker RL, Hume JR, Horowitz B. Differential expression and alternative splicing of TRP channel genes in smooth muscles. Am J Cell Physiol. 2001;280:C1184-C1192.
22. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol. 2003;284:C316-C330.
23. Karamsetty VS, Kane KA, Wadsworth RM. The effects of chronic hypoxia on the pharmacological responsiveness of the pulmonary artery. Pharmacol Ther. 1995;68:233-246.
24. MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol. 1996;119:917-930.
25. 2+ Signaling Between Inositol Trisphosphate- and Ryanodine-Receptors. Am J Physiol Lung Cell Mol Physiol. 2003:L680-L690.
26. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol. 1999;517:121-134.
27. 2+ entry pathway. FASEB J. 2001;15:1727-1738.
28. Robertson TP, Hague D, Aaronson PI, Ward JP. Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat. J Physiol. 2000;525:669-680.
29. Sinkins WG, Estacion M, Schilling WP. Functional expression of TrpC1: a human homologue of the Drosophila Trp channel. Biochem J. 1998;331:331-339.
30. Goel M, Sinkins WG, Schilling WP. Selective Association of TRPC Channel Subunits in Rat Brain Synaptosomes. J Biol Chem. 2002;277:48303-48310.
31. Hofmann T, Schaefer M, Schultz G, Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA. 2002;99:7461-7466.
32. Kiselyov K, Xu X, Mozhayeva G, Kuo T, Pessah I, Mignery G, Zhu X, Birnbaumer L, Muallem S. Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature. 1998;396:478-482.
33. Semenza GL. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res. 2000;1:159-162.
34. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest. 1999;103:691-696.
35. 2+ entry and the regulation of smooth muscle tone. Trends Pharmacol Sci. 1998; 19:266-269.
36. + entry via store-operated channels modulates Ca(2+) signaling in arterial myocytes. Am J Physiol Cell Physiol, 2000;278:C163-C173.
37. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res. 2002;90:248-250.
38. Launay JM, Herve P, Peoc'h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med. 2002;8:1129-1135.
39. Li H, Chen SJ, Chen YF, Meng QC, Durand J, Oparil S, Elton TS. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol. 1994;77:1451-1459.
40. 2+-permeable nonselective cation channel by endothelin-1 in A7r5 cells. Br J Pharmacol. 1998;124:1541-1549.
41. 2+ channels involved in endothelin-1-induced mitogenic responses in vascular smooth muscle cells. Eur J Pharmacol. 2001;422:15-21.